Home > Boards > US Listed > Biotechs > Galera Therapeutics, Inc. (GRTX)

6.90 at this post. 6s are done. Collapse..

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Dr._Paddleboarder Member Profile
 
Followed By 14
Posts 1,388
Boards Moderated 0
Alias Born 08/01/19
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/6/2021 7:06:47 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 12/10/2020 6:04:06 AM
Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire Inc. - 11/20/2020 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/17/2020 4:07:24 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2020 7:32:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/10/2020 7:08:45 AM
Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates GlobeNewswire Inc. - 11/10/2020 7:00:00 AM
Galera Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference GlobeNewswire Inc. - 11/3/2020 8:00:00 AM
Galera Therapeutics Announces Interim Data from Pilot Phase 1/2 Trial of GC4419 in Combination with Stereotactic Body Radiati... GlobeNewswire Inc. - 10/27/2020 3:00:10 PM
Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419... GlobeNewswire Inc. - 10/23/2020 5:00:10 PM
Galera Therapeutics Announces Dosing of First Patient in the Phase 1/2 GRECO-1 Clinical Trial of GC4711 in Combination with S... GlobeNewswire Inc. - 10/22/2020 8:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/7/2020 5:02:22 PM
Galera Therapeutics to Host Virtual KOL Event on the Treatment of Locally Advanced Pancreatic Cancer GlobeNewswire Inc. - 9/22/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/16/2020 8:08:34 AM
Galera Therapeutics Announces Dosing of First Patient in a Randomized, Double-Blind Pilot Phase 2 Clinical Trial of GC4419 fo... GlobeNewswire Inc. - 9/16/2020 8:00:10 AM
Galera Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit GlobeNewswire Inc. - 9/14/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2020 7:02:34 AM
Galera Therapeutics Announces ASTRO Late-Breaker Presentation of Topline Safety and Efficacy Data from its Double-Blind, Plac... GlobeNewswire Inc. - 9/8/2020 8:00:10 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 7:32:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 7:11:51 AM
Galera Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates GlobeNewswire Inc. - 8/10/2020 7:00:10 AM
Galera Therapeutics to Participate in Fireside Chat at 2020 BTIG Virtual Biotechnology Conference GlobeNewswire Inc. - 7/30/2020 8:00:10 AM
Galera Therapeutics Completes Enrollment of Phase 1b/2a Clinical Trial of GC4419 in Combination with Radiotherapy for Locally... GlobeNewswire Inc. - 7/13/2020 5:46:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/22/2020 4:53:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2020 5:48:08 PM
Dr._Paddleboarder   Wednesday, 03/18/20 10:03:44 AM
Re: None
Post # of 27 
6.90 at this post. 6s are done. Collapse..

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences